Light Mode
$33.48 ↑ +0.00 (+0.00%) Trading Up from the previous close of $33.48, $1.46 below the day’s high of $34.94
+10.14 (+43.44%) / 6M
Momentum, market sentiment, and recent alerts
URGN reads poor: price sits above one of the two key moving averages, the 12-month move is +69.3%.
Earnings, valuation, and balance sheet
Company profile and competitor comparison
UroGen Pharma Ltd. is a biopharmaceutical company, which engages in developing and commercializing innovative solutions that treat urothelial and specialty cancers. It also focuses on developing RTGel reverse-thermal hydrogel, a proprietary sustained release and hydrogel-based platform technology. The company was founded by Asher Holzer in 2004 and is headquartered in Princeton, NJ.
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.